Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Other assay [8]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 35-6300 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- MAGE1 Monoclonal Antibody (6C1)
- Antibody type
- Monoclonal
- Antigen
- Recombinant full-length protein
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 6C1
- Vial size
- 100 µg
- Concentration
- 0.5 mg/mL
- Storage
- -20°C
Submitted references A Preliminary Study of the Cross-Reactivity of Canine MAGE-A with Hominid Monoclonal Antibody 6C1 in Canine Mammary Gland Tumors: An Attractive Target for Cancer Diagnostic, Prognostic and Immunotherapeutic Development in Dogs.
Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A.
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts.
Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival.
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.
Expression of family A melanoma antigen in human gastric carcinoma.
Srisawat W, Nambooppha B, Pringproa K, Thongtharb A, Prachasilchai W, Sthitmatee N
Veterinary sciences 2020 Aug 10;7(3)
Veterinary sciences 2020 Aug 10;7(3)
Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A.
Pourmaleki M, Young JH, Socci ND, Chiang S, Edelweiss M, Li Y, Zhang M, Roshal L, Chi DS, Busam KJ, Mellinghoff IK, Hollmann TJ
Oncotarget 2019 Oct 22;10(58):6152-6167
Oncotarget 2019 Oct 22;10(58):6152-6167
Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts.
Srivastava P, Paluch BE, Matsuzaki J, James SR, Collamat-Lai G, Karbach J, Nemeth MJ, Taverna P, Karpf AR, Griffiths EA
Leukemia research 2014 Nov;38(11):1332-41
Leukemia research 2014 Nov;38(11):1332-41
Melanoma-associated cancer-testis antigen 16 (CT16) regulates the expression of apoptotic and antiapoptotic genes and promotes cell survival.
Nylund C, Rappu P, Pakula E, Heino A, Laato L, Elo LL, Vihinen P, Pyrhönen S, Owen GR, Larjava H, Kallajoki M, Heino J
PloS one 2012;7(9):e45382
PloS one 2012;7(9):e45382
Heterogeneous expression of GAGE, NY-ESO-1, MAGE-A and SSX proteins in esophageal cancer: Implications for immunotherapy.
Akcakanat A, Kanda T, Tanabe T, Komukai S, Yajima K, Nakagawa S, Ohashi M, Hatakeyama K
International journal of cancer 2006 Jan 1;118(1):123-8
International journal of cancer 2006 Jan 1;118(1):123-8
Expression of family A melanoma antigen in human gastric carcinoma.
Jung EJ, Kim MA, Lee HS, Yang HK, Lee YM, Lee BL, Kim WH
Anticancer research 2005 May-Jun;25(3B):2105-11
Anticancer research 2005 May-Jun;25(3B):2105-11
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 Positive cross-reactivity of MAb 6C1, testis and canines. The detection of MAGE antigen in canine testicular tissue sections at different dilutions using IHC method (40x). ( a - e ) MAb 6C1 in phosphate buffer solution (PBS) in dilutions of 1:100, 1:200, 1:400, 1:800 and 1:1000, respectively; ( f ) negative control (normal mouse serum in PBS in a dilution of 1:200).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 3 Positive cross-reactivity of MAb 6C1, mammary gland tumors and canines. Location of MAGE expression in the complex carcinoma type of malignant mammary gland tumor section Ma1: ( a ) HE stained, 40x; ( b ) IHC-stained-positive, 40x; ( c ) IHC-stained-positive, 100x black arrows are representative of nuclear expression pattern; red arrows are representative of nuclear-cytoplasmic expression pattern.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 4 Positive cross-reactivity of MAb 6C1, mammary gland tumors and canines. Location of MAGE expression in the simple tubular carcinoma type of malignant mammary gland tumor section Ma2: ( a ) HE stained, 40x; ( b ) IHC-stained-positive, 40x, ( c ) IHC-stained-positive, 100x, black arrows are representative of nuclear expression pattern.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 1 Representative images of immunohistochemistry for B7-H3, B7-H4, PD-L1, PD-L2, MAGE-A, NY-ESO-1, MHC-I, and B2M in in situ and invasive EMPD. IHC images for each marker along with the corresponding H&E image for each case are shown for in situ and invasive EMPD.